← Back
$ALNY All transactions

ALNYLAM PHARMACEUTICALS, INC.

▼ SELL 10b5-1 Plan

$ Value

$65K

Shares

144

Price

$452

Filed

Sep 2

Insider

Name

Tanguler Tolga

Title

EVP, Chief Commercial Officer

CIK

0001849458

Roles

Officer

Transaction Details

Transaction Date

2025-08-29

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

25,992

Footnotes

This transaction was made pursuant to a Rule 10b5-1(c) trading plan adopted by the Reporting Person on May 27, 2025. | The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $445.32 to $445.79. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. | The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $446.34 to $447.34. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. | The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $447.59 to $448.58. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. | The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $449.07 to $449.98. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. | The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $451.21 to $451.68. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. | The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $452.22 to $452.54. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Filing Info

Accession No.

0001735276-25-000094

Form Type

4

Issuer CIK

0001178670

Tanguler Tolga's History

Date Ticker Type Value
2026-03-04 ALNY $34K
2026-03-04 ALNY $33K
2026-03-04 ALNY $69K
2026-03-04 ALNY $93K
2026-03-04 ALNY $113K
2026-03-04 ALNY $248K
2026-03-04 ALNY $88K
2026-03-04 ALNY $68K
2026-03-02 ALNY A $0
2026-03-02 ALNY $15K

Other Insiders at ALNY (90d)

Insider Bought Sold Last
Greenstreet Yvonne
Chief Executive Officer
$5.3M 2026-03-04
SUPRAN BRYAN
EVP, CLO and Secretary
2026-03-02
Poulton Jeffrey V.
EVP, Chief Financial Officer
$2.2M 2026-03-04
Garg Pushkal
EVP Chief R&D
$4.9M 2026-03-05
Tanguler Tolga
EVP, Chief Commercial Officer
$1.9M 2026-03-04
Fitzgerald Kevin Joseph
CSO & EVP, Head of Research
$2.8M 2026-03-05
McLaughlin Melissa
Chief Human Resources Officer
$1.3M 2026-04-06